Literature DB >> 1984449

Induction of NF-KB during monocyte differentiation by HIV type 1 infection.

M Suzan1, D Salaun, C Neuveut, B Spire, I Hirsch, P Le Bouteiller, G Querat, J Sire.   

Abstract

The production of human immunodeficiency virus type 1 (HIV-1) progeny was followed in the U937 promonocytic cell line after stimulation either with retinoic acid or PMA, and in purified human monocytes and macrophages. Electrophoretic mobility shift assays and Southwestern blotting experiments were used to detect the binding of cellular transactivation factor NF-KB to the double repeat-KB enhancer sequence located in the long terminal repeat. PMA treatment, and not retinoic acid treatment of the U937 cells acts in inducing NF-KB expression in the nuclei. In nuclear extracts from monocytes or macrophages, induction of NF-KB occurred only if the cells were previously infected with HIV-1. When U937 cells were infected with HIV-1, no induction of NF-KB factor was detected, whereas high level of progeny virions was produced, suggesting that this factor was not required for viral replication. These results indicate that in monocytic cell lineage, HIV-1 could mimic some differentiation/activation stimuli allowing nuclear NF-KB expression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1984449

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Constitutive expression of p50 homodimer in freshly isolated human monocytes decreases with in vitro and in vivo differentiation: a possible mechanism influencing human immunodeficiency virus replication in monocytes and mature macrophages.

Authors:  S R Lewin; P Lambert; N J Deacon; J Mills; S M Crowe
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  NF-kappaB cis-acting motifs of the human immunodeficiency virus (HIV) long terminal repeat regulate HIV transcription in human macrophages.

Authors:  S Asin; G D Bren; E M Carmona; N J Solan; C V Paya
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  Diazepam-mediated inhibition of human immunodeficiency virus type 1 expression in human brain cells.

Authors:  J R Lokensgard; G Gekker; S Hu; A F Arthur; C C Chao; P K Peterson
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

4.  Growth hormone activation of human monocytes for superoxide production but not tumor necrosis factor production, cell adherence, or action against Mycobacterium tuberculosis.

Authors:  J Warwick-Davies; D B Lowrie; P J Cole
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

5.  The response of gamma interferon activation factor is under developmental control in cells of the macrophage lineage.

Authors:  A Eilers; D Seegert; C Schindler; M Baccarini; T Decker
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

Review 6.  Benzodiazepines, glia, and HIV-1 neuropathogenesis.

Authors:  J R Lokensgard; C C Chao; G Gekker; S Hu; P K Peterson
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

7.  The Ras-Raf pathway is activated in human immunodeficiency virus-infected monocytes and particpates in the activation of NF-kappa B.

Authors:  L Folgueira; A Algeciras; W S MacMorran; G D Bren; C V Paya
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

8.  Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism.

Authors:  J W Maciaszek; D A Talmage; G A Viglianti
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

9.  Chronic human immunodeficiency virus type 1 infection stimulates distinct NF-kappa B/rel DNA binding activities in myelomonoblastic cells.

Authors:  A Roulston; P Beauparlant; N Rice; J Hiscott
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

10.  Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.

Authors:  E V Granowitz; B M Saget; M Z Wang; C A Dinarello; P R Skolnik
Journal:  Mol Med       Date:  1995-09       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.